Curium Is Said to Near About $7 Billion Acquisition of Lantheus
Summary
Curium is in advanced talks to buy Lantheus Holdings in a deal valued at about $7 billion. The transaction could be announced within days, according to people familiar with the talks.
Consolidation in radiopharma is accelerating as buyers chase scarce production capacity and late-stage imaging and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Radiopharma scale can determine whether health systems get timely imaging and therapy or face higher costs and supply constraints.